Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Oxidized HDL and Isoprostane Exert a Potent Adipogenic Effect on Stem Cells: Where in the Lineage?

Peterson SJ, Vanella L, Bialczak A, Schragenheim J, Li M, Bellner L, Shapiro JI, Abraham NG.

Cell Stem Cells Regen Med. 2016;2(1). doi: 10.16966/2472-6990.109. Epub 2016 Apr 27. No abstract available.

2.

Human induced pluripotent stem cell‑derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses.

Shi H, Liang M, Chen W, Sun X, Wang X, Li C, Yang Y, Yang Z, Zeng W.

Mol Med Rep. 2018 Jan;17(1):1461-1468. doi: 10.3892/mmr.2017.8075. Epub 2017 Nov 15.

3.

Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.

Gao D, Podrez EA.

Free Radic Biol Med. 2018 Feb 1;115:57-67. doi: 10.1016/j.freeradbiomed.2017.11.012. Epub 2017 Nov 15.

PMID:
29155052
4.

Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function.

Lv P, Zhao M, Liu Y, Jin H, Cui W, Fan C, Teng Y, Zheng L, Huang Y.

Int J Mol Med. 2018 Jan;41(1):61-68. doi: 10.3892/ijmm.2017.3216. Epub 2017 Oct 27.

5.

Lipid abnormalities in patients with Rheumatoid Arthritis.

Erum U, Ahsan T, Khowaja D.

Pak J Med Sci. 2017 Jan-Feb;33(1):227-230. doi: 10.12669/pjms.331.11699.

6.

Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.

Jorissen W, Wouters E, Bogie JF, Vanmierlo T, Noben JP, Sviridov D, Hellings N, Somers V, Valcke R, Vanwijmeersch B, Stinissen P, Mulder MT, Remaley AT, Hendriks JJ.

Sci Rep. 2017 Feb 23;7:43410. doi: 10.1038/srep43410.

7.

Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD.

Hayashi K, Takayama M, Abe T, Kanda T, Hirose H, Shimizu-Hirota R, Shiomi E, Iwao Y, Itoh H.

J Atheroscler Thromb. 2017 Aug 1;24(8):863-875. doi: 10.5551/jat.38612. Epub 2017 Jan 26.

8.

A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.

McGarrah RW, Kelly JP, Craig DM, Haynes C, Jessee RC, Huffman KM, Kraus WE, Shah SH.

Clin Chem. 2017 Jan;63(1):288-296. doi: 10.1373/clinchem.2016.261636. Epub 2016 Nov 3.

9.

Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.

Jayaraman S, Haupt C, Gursky O.

J Lipid Res. 2016 Dec;57(12):2138-2149. Epub 2016 Oct 15.

10.

Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.

Sodhi K, Bracero L, Feyh A, Nichols A, Srikanthan K, Latif T, Preston D, Shapiro JI, Elitsur Y.

J Clin Cell Immunol. 2016 Feb;7(1). pii: 393. Epub 2016 Feb 17.

11.

Association between two common polymorphisms (single nucleotide polymorphism -250G/A and -514C/T) of the hepatic lipase gene and coronary artery disease in type 2 diabetic patients.

Mohammadzadeh G, Ghaffari MA, Bazyar M, Kheirollah A.

Adv Biomed Res. 2016 Feb 15;5:27. doi: 10.4103/2277-9175.176366. eCollection 2016.

12.

High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort.

McGarrah RW, Craig DM, Haynes C, Dowdy ZE, Shah SH, Kraus WE.

Atherosclerosis. 2016 Mar;246:229-35. doi: 10.1016/j.atherosclerosis.2016.01.012. Epub 2016 Jan 11.

13.

Serum amyloid A impairs the antiinflammatory properties of HDL.

Han CY, Tang C, Guevara ME, Wei H, Wietecha T, Shao B, Subramanian S, Omer M, Wang S, O'Brien KD, Marcovina SM, Wight TN, Vaisar T, de Beer MC, de Beer FC, Osborne WR, Elkon KB, Chait A.

J Clin Invest. 2016 Jan;126(1):266-81. doi: 10.1172/JCI83475. Epub 2015 Dec 7. Erratum in: J Clin Invest. 2016 Feb;126(2):796.

14.

HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Annema W, Dikkers A, de Boer JF, Dullaart RP, Sanders JS, Bakker SJ, Tietge UJ.

J Am Soc Nephrol. 2016 Feb;27(2):595-603. doi: 10.1681/ASN.2014090857. Epub 2015 Aug 28.

15.

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.

Krychtiuk KA, Kastl SP, Pfaffenberger S, Pongratz T, Hofbauer SL, Wonnerth A, Katsaros KM, Goliasch G, Gaspar L, Huber K, Maurer G, Dostal E, Oravec S, Wojta J, Speidl WS.

Atherosclerosis. 2014 Dec;237(2):589-96. doi: 10.1016/j.atherosclerosis.2014.10.015. Epub 2014 Oct 18.

16.

Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes.

Russo GT, Giandalia A, Romeo EL, Alibrandi A, Horvath KV, Asztalos BF, Cucinotta D.

Int J Endocrinol. 2014;2014:607924. doi: 10.1155/2014/607924. Epub 2014 Sep 2.

17.

Association of serum uric acid and coronary artery disease in premenopausal women.

Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW, Zhou YJ.

PLoS One. 2014 Sep 3;9(9):e106130. doi: 10.1371/journal.pone.0106130. eCollection 2014.

18.

Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.

Smith CK, Vivekanandan-Giri A, Tang C, Knight JS, Mathew A, Padilla RL, Gillespie BW, Carmona-Rivera C, Liu X, Subramanian V, Hasni S, Thompson PR, Heinecke JW, Saran R, Pennathur S, Kaplan MJ.

Arthritis Rheumatol. 2014 Sep;66(9):2532-2544. doi: 10.1002/art.38703.

19.

Glycomic analysis of high density lipoprotein shows a highly sialylated particle.

Huang J, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB.

J Proteome Res. 2014 Feb 7;13(2):681-91. doi: 10.1021/pr4012393. Epub 2014 Jan 21.

20.

Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.

Tehrani DM, Gardin JM, Yanez D, Hirsch CH, Lloyd-Jones DM, Stein PK, Wong ND.

Atherosclerosis. 2013 Dec;231(2):246-51. doi: 10.1016/j.atherosclerosis.2013.08.036. Epub 2013 Sep 5.

Supplemental Content

Support Center